Vanguard Group
MDRX

Vanguard Group’s Veradigm Inc. Common Stock MDRX Stock Holding History

Vanguard Group’s Portfolio MDRX Stock Details MDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-14,275,875
Closed -$150M – 4520
2023
Q4 		$150M Buy
14,275,875
+95,291
+0.7% +$1.17M ﹤0.01% 1655
2023
Q3 		$186M Sell
14,180,584
-23,420
-0.2% -$307K ﹤0.01% 1462
2023
Q2 		$179M Buy
14,204,004
+82,401
+0.6% +$1M ﹤0.01% 1525
2023
Q1 		$184M Buy
14,121,603
+571,034
+4% +$9.25M ﹤0.01% 1493
2022
Q4 		$239M Sell
13,550,569
-2,794
-0% -$46.8K 0.01% 1336
2022
Q3 		$206M Sell
13,553,363
-581,635
-4% -$9.41M 0.01% 1365
2022
Q2 		$210M Buy
14,134,998
+282,524
+2% +$5.28M 0.01% 1391
2022
Q1 		$312M Buy
13,852,474
+584,339
+4% +$11.8M 0.01% 1272
2021
Q4 		$245M Sell
13,268,135
-107,171
-0.8% -$1.7M 0.01% 1477
2021
Q3 		$179M Sell
13,375,306
-1,608,706
-11% -$26M ﹤0.01% 1675
2021
Q2 		$277M Sell
14,984,012
-945,924
-6% -$15.9M 0.01% 1420
2021
Q1 		$239M Sell
15,929,936
-43,389
-0.3% -$695K 0.01% 1482
2020
Q4 		$231M Sell
15,973,325
-183,424
-1% -$2.22M 0.01% 1388
2020
Q3 		$132M Sell
16,156,749
-1,562,952
-9% -$12.8M ﹤0.01% 1539
2020
Q2 		$120M Buy
17,719,701
+758,892
+4% +$4.92M ﹤0.01% 1578
2020
Q1 		$119M Buy
16,960,809
+1,284,446
+8% +$10.4M 0.01% 1427
2019
Q4 		$154M Sell
15,676,363
-1,064,223
-6% -$11.2M 0.01% 1535
2019
Q3 		$184M Buy
16,740,586
+217,050
+1% +$2.23M 0.01% 1382
2019
Q2 		$192M Buy
16,523,536
+363,005
+2% +$3.69M 0.01% 1381
2019
Q1 		$154M Buy
16,160,531
+149,164
+0.9% +$1.65M 0.01% 1510
2018
Q4 		$154M Buy
16,011,367
+160,183
+1% +$1.79M 0.01% 1419
2018
Q3 		$226M Buy
15,851,184
+153,769
+1% +$2.09M 0.01% 1292
2018
Q2 		$188M Buy
15,697,415
+311,447
+2% +$3.84M 0.01% 1391
2018
Q1 		$190M Buy
15,385,968
+271,750
+2% +$3.86M 0.01% 1320
2017
Q4 		$220M Buy
15,114,218
+143,156
+1% +$1.99M 0.01% 1252
2017
Q3 		$213M Buy
14,971,062
+146,422
+1% +$1.89M 0.01% 1232
2017
Q2 		$189M Buy
14,824,640
+181,721
+1% +$2.21M 0.01% 1264
2017
Q1 		$186M Buy
14,642,919
+519,798
+4% +$6.16M 0.01% 1272
2016
Q4 		$144M Buy
14,123,121
+39,611
+0.3% +$452K 0.01% 1389
2016
Q3 		$185M Sell
14,083,510
-19,604
-0.1% -$262K 0.01% 1159
2016
Q2 		$179M Buy
14,103,114
+561,744
+4% +$7.45M 0.01% 1116
2016
Q1 		$179M Buy
13,541,370
+691,335
+5% +$9.08M 0.01% 1090
2015
Q4 		$198M Buy
12,850,035
+248,433
+2% +$3.56M 0.01% 1021
2015
Q3 		$156M Buy
12,601,602
+707,537
+6% +$9.74M 0.01% 1141
2015
Q2 		$163M Buy
11,894,065
+953,137
+9% +$12.9M 0.01% 1197
2015
Q1 		$131M Buy
10,940,928
+467,049
+4% +$5.71M 0.01% 1312
2014
Q4 		$134M Buy
10,473,879
+211,795
+2% +$2.7M 0.01% 1221
2014
Q3 		$138M Buy
10,262,084
+71,934
+0.7% +$1.09M 0.01% 1147
2014
Q2 		$164M Buy
10,190,150
+22,373
+0.2% +$349K 0.01% 1083
2014
Q1 		$183M Buy
10,167,777
+352,350
+4% +$6.1M 0.02% 967
2013
Q4 		$152M Buy
9,815,427
+411,582
+4% +$6.06M 0.01% 1057
2013
Q3 		$140M Buy
9,403,845
+153,632
+2% +$2.32M 0.01% 1029
2013
Q2 		$120M Buy
+9,250,213
New +$124M 0.01% 1049

Other funds holding MDRX

SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
TCM
Tyro Capital Management Miami, Florida $921M AUM 60.37% 1-Year Est. Return
OFCM
One Fin Capital Management San Francisco, California $280M AUM 49.87% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group's MDRX Position: Q1 2024 in Review

Vanguard Group sold out of Veradigm Inc. Common Stock (MDRX) in Q1 2024, closing a stake of 14,275,875 shares — an estimated $150M sold.

Vanguard Group first reported a position in MDRX in Q2 2013 and held it in 43 quarters. The position peaked at $312M in Q1 2022. 35 funds tracked by Wall St. Rank hold MDRX as of Q1 2024.

  • Vanguard Group reported no remaining Veradigm Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Vanguard Group sold 14,275,875 Veradigm Inc. Common Stock shares in Q1 2024, an estimated $150M.
  • Vanguard Group first reported a position in Veradigm Inc. Common Stock in Q2 2013 and held it in 43 quarters.
  • Vanguard Group's Veradigm Inc. Common Stock position peaked at $312M in Q1 2022.
  • 35 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q1 2024.

Based on Vanguard Group's 13F filing for Q1 2024, filed 10 May 2024.